Kv1.3 blockade(Muna Therapeutics)

N/A

Report date: 2025/10/24 17:30:27
NME

Base Information

Drug NameKv1.3 blockade(Muna Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsParkinson DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMuna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMuna Therapeutics
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A